Acyclovir

Product NDC
55289-273
11-digit product format
552890273
Labeler code
55289
Product ID
55289-273_7bc03ef2-5cc7-03db-e053-2a91aa0a3b09
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Acyclovir
Dosage form
CAPSULE
Route
ORAL
Labeler
PD-Rx Pharmaceuticals, Inc.
Application
ANDA074578
Marketing category
ANDA
Marketing start
1997-04-23
Marketing end
0000-00-00
Substance
ACYCLOVIR
Active strength
200 mg/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
55289-273-05EA - Each55289-273f8f885b7-2d16-4892-878e-f5642b15999412014-08-01
55289-273-10EA - Each55289-2731cb82d25-f98d-4f5e-98e7-0b5dc4c3ea3612013-06-04
55289-273-25EA - Each55289-2739ee1fa98-bd3f-4670-b5cf-7748a8b7855612013-06-04
55289-273-30EA - Each55289-273df07bc91-934c-484a-a6fe-8b960f0ce28412013-06-04
55289-273-35EA - Each55289-273709b502a-cb9e-4a94-8294-bdd2d1ea2cbd12013-06-04
55289-273-50EA - Each55289-2739a59ccb7-4f41-4e57-a064-d24771f9361b12013-06-04